Table 2 The percentage of antimicrobial susceptibility of NIs in an Iranian referral pediatrics hospital
Bacteria | Gentamycin | Trimethoprim sulfamethoxazole | Imipenem | Nitrofourantoin | Cefotaxime | Clindamycin | Ampicillin | Ceftazidim | Penicillin |
|---|---|---|---|---|---|---|---|---|---|
E. coli | 58.6% | 16.7% | 22.2% | 100% | 12.5% | – | 0% | 33.3% | 22.7% |
Enterococcus spp. | 23.5% | 100% | 50% | 88.9% | 0% | 0% | 26.9% | – | – |
Psuedomonas spp. | 23.8% | – | 84.2% | – | – | – | – | 79.2% | – |
P. aureoginosa | 72.7% | 75% | 80.4% | – | 62.5% | – | – | 80.8% | – |
K. pneumonia | 37.5% | 37.2% | 52.9% | 33.3% | 4.4% | 100% | 100% | 100% | – |
CONS | 0% | 35.4% | – | 50% | 0% | 18.6% | 0% | – | 0% |
S. aureus | 0% | 78.3% | 100% | 100% | – | 45.5% | – | – | 14.3% |
Enterobacter spp. | 50% | 36.4% | 100% | 0% | 14.3% | – | 0% | 100% | 0% |
Acinetobacter baumannii | 23.7% | 9.4% | 5.3% | – | 2.4% | – | 16.7% | 5.3% | – |
Serratia marcescens | 13.6% | 100% | 100% | – | 16% | – | – | 100% | – |
Stenotrophomonas maltophilia | 0% | 100% | 0% | – | – | – | – | – | 0% |
Candida spp. | – | – | – | – | – | – | – | – |  |
Streptococcus spp. | – | 0% | – | – | – | 50% | 100% | – | 100% |
Burkholderia cepacia | 33.3% | 100% | 33.3% | 0% | 100% | – | 0% | 66.7% | – |
Morganella morganii | 50% | 100% | – | – | 100% | – | – | – | – |
Total | 41.1% | 48.4% | 59.4% | 63.8% | 10.1% | 29.6% | 29.5% | 56.5% | 12.6% |
Bacteria | Vancomycin | Colistin | Methicillin | Erythromycin | Ciprofloxacin | Tazocin | Linezolide | Amikacin | Cefepime |
|---|---|---|---|---|---|---|---|---|---|
E. coli | – | 100% | – | – | 50.00% | 59.3% | – | 78.1% | 17.9% |
Enterococcus spp. | 36% | – | – | 0% | 0% | 40% | 100% | 60% | 66.7% |
Psuedomonas spp. | – | 100% | – | – | 100% | 90% | – | 34.8% | 50% |
P. aureoginosa | 100% | 50% | – | – | 75% | 78.4% | – | 81.8% | 62% |
K. pneumonia | 100% | 100% | – | – | 55.6% | 23.8% | – | 25.5% | 11.5% |
CONS | 100% | – | 14.3% | 4.5% | – | 100% | – | 50% | – |
S. aureus | 100% | – | 54.5% | 35% | 0% | – | – | – | – |
Enterobacter spp. | 0.00% | – | – | – | 33.3% | 68.4% | 100% | 73.7% | 47.1% |
Acinetobacter baumannii | – | 100% | – | – | 10% | 9.4% | – | 9.8% | 5.6% |
Serratia marcescens | – | 100% | – | – | 33.3% | 10% | – | 24% | 0% |
Stenotrophomonas maltophilia | – | – | – | 100% | 96.4% | – | – | 0% | – |
Candida spp. | 100% | – | – | – | – | – | – | – | – |
Streptococcus spp. | 100% | – | – | 0% | – | – | – | – | – |
Burkholderia cepacia | – | 0% | – | – | 50% | 66.7% | – | 0% | 0% |
Morganella morganii | – | – | – | – | – | 100% | 100% | 100% | 100% |
Total | 85.2% | 96.9% | 28.1% | 14.7% | 49.4% | 44.8% | 100% | 43.0% | 26.8% |